These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27485941)

  • 1. Patient Variables Associated with Nafcillin Plasma Concentrations and Toxicity.
    Benefield RJ; Barker BC; Gast CM; Alexander DP
    Pharmacotherapy; 2016 Sep; 36(9):994-1002. PubMed ID: 27485941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions in home care patients receiving nafcillin or oxacillin.
    Dahlgren AF
    Am J Health Syst Pharm; 1997 May; 54(10):1176-9. PubMed ID: 9161625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials.
    Maraqa NF; Gomez MM; Rathore MH; Alvarez AM
    Clin Infect Dis; 2002 Jan; 34(1):50-4. PubMed ID: 11731945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Events Lead to Drug Discontinuation More Commonly among Patients Who Receive Nafcillin than among Those Who Receive Oxacillin.
    Viehman JA; Oleksiuk LM; Sheridan KR; Byers KE; He P; Falcione BA; Shields RK
    Antimicrob Agents Chemother; 2016 May; 60(5):3090-5. PubMed ID: 26976858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of nafcillin in patients with cirrhosis and extrahepatic biliary obstruction.
    Marshall JP; Salt WB; Elam RO; Wilkinson GR; Schenker S
    Gastroenterology; 1977 Dec; 73(6):1388-92. PubMed ID: 913979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and renal dysfunction following nafcillin administration.
    Lestico MR; Vick KE; Hetsko CM
    Ann Pharmacother; 1992; 26(7-8):985-90. PubMed ID: 1504413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
    Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
    PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with preventability, predictability, and severity of adverse drug reactions.
    Gholami K; Shalviri G
    Ann Pharmacother; 1999 Feb; 33(2):236-40. PubMed ID: 10084421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Drug Reactions in Patients Receiving Systemic Antifungal Therapy at a High-Complexity Hospital.
    de Souza MC; Santos AG; Reis AM
    J Clin Pharmacol; 2016 Dec; 56(12):1507-1515. PubMed ID: 27198583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections.
    Kancir LM; Tuazon CU; Cardella TA; Sheagren JN
    Arch Intern Med; 1978 Jun; 138(6):909-11. PubMed ID: 646562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of an interaction between nifedipine and nafcillin in humans.
    Lang CC; Jamal SK; Mohamed Z; Mustafa MR; Mustafa AM; Lee TC
    Br J Clin Pharmacol; 2003 Jun; 55(6):588-90. PubMed ID: 12814453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four cases of nafcillin-associated acute interstitial nephritis in one institution.
    Hoppes T; Prikis M; Segal A
    Nat Clin Pract Nephrol; 2007 Aug; 3(8):456-61. PubMed ID: 17653125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions.
    Seifert CF; Kennedy S
    Pharmacotherapy; 2004 Jun; 24(6):776-83. PubMed ID: 15222668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and cerebrospinal fluid concentration of nafcillin in pediatric patients undergoing cerebrospinal fluid shunt placement.
    Nahata MC; Fan-Havard P; Kosnik EJ; Bartkowski MH; Barson WJ
    Chemotherapy; 1990; 36(2):98-102. PubMed ID: 2311446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of antiretrovirals in HIV-infected pregnant women.
    Zuk DM; Hughes CA; Foisy MM; Robinson JL; Singh AE; Houston S
    Ann Pharmacother; 2009 Jun; 43(6):1028-35. PubMed ID: 19491318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents.
    Nguyen JK; Fouts MM; Kotabe SE; Lo E
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):36-41. PubMed ID: 16730619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study.
    Huwyler T; Lenggenhager L; Abbas M; Ing Lorenzini K; Hughes S; Huttner B; Karmime A; Uçkay I; von Dach E; Lescuyer P; Harbarth S; Huttner A
    Clin Microbiol Infect; 2017 Jul; 23(7):454-459. PubMed ID: 28111294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.